FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/092523 [Registered on: 06/08/2025] Trial Registered Prospectively
Last Modified On: 30/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Preventive
Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Study to Find Out How Vibhitaki Capsules and Vacha Dhupana Therapy Help Improve Sleep in Working Women with Sleeplessness 
Scientific Title of Study   An Open Label Comparative Clinical Study To Evaluate The Effect Of Vibhitaki Phala MajjaTerminalia Belerica Capsule and Aromatherapy With Vacha Acrus Calamus Linn Dhupa in Working Women VisAVis Primary Insomnia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sughosh S Mujumdar 
Designation  M.D. Scholar (Manasaroga) 
Affiliation  Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi 
Address  OPD-3/OPD-7, Department of Manasaroga, Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi

Udupi
KARNATAKA
574118
India 
Phone  8867752511  
Fax    
Email  sughosh.muj@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vijayendra G Bhat 
Designation  B.A.M.S, MD (AYU) 
Affiliation  Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi 
Address  Department of Manasaroga, Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi

Udupi
KARNATAKA
574118
India 
Phone  9448139919  
Fax    
Email  ayurvijay25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sughosh S Mujumdar 
Designation  M.D. Scholar (Manasaroga) 
Affiliation  Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi 
Address  OPD3/OPD7, Department of Manasaroga, Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi

Udupi
KARNATAKA
574118
India 
Phone  8867752511  
Fax    
Email  sughosh.muj@gmail.com  
 
Source of Monetary or Material Support  
Shri Dharmashtala Manjunatheswara Ayurveda Pharmacy, Laxminarayana Nagar, P.O Kuthpady, Udupi, Karnataka, India - 574118 
 
Primary Sponsor  
Name  nil 
Address  nil 
Type of Sponsor  Other [nil] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sughosh S Mujumdar  Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research Centre, Kuthpady, Udupi  OPD3/OPD7, Department of Manasaroga, Shri Dharmashtala Manjunatheswara College of Ayurveda, Hospital and Research centre, Kuthpady, Udupi.
Udupi
KARNATAKA 
8867752511

sughosh.muj@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Clearance Committee Human  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F510||Insomnia not due to a substance orknown physiological condition. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Vibhitaki phala majja, Reference: Priya Vrat Sharma Classical uses of Medicinal Plants Chaukhambha Visvabharati 2004 p 334, Route: Oral, Dosage Form: Churna/ Powder, Dose: 400(mg), Frequency: hs, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: warm water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Vacha, Reference: Priya Vrat Sharma Classical uses of Medicinal Plants Chaukhambha Visvabharati 2004 p 334, Route: Nasal, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: hs, Bhaishajya Kal: Pragbhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: Dhupana
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1) Working women fulfilling diagnostic criteria of Insomnia as per DSM-5 and ICD-10.
2) Patients are selected of age group between 20-40years.
3) Patients willing to sign informed consent. 
 
ExclusionCriteria 
Details  1) Patients suffering from any systemic illness, psychiatric illness or disorder and
other metabolic disorders interfering with the treatment protocol.
2) Pregnant and lactating women.
3) Patient suffering from Substance abuse, Circadian rhythm disorder, Parasomnia. 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment criteria:
Parameters will be scored by standard method and will be assessed before and after treatment on
0 th , 14 th and 28 th day and will be analysed statistically.
1) Athens insomnia scale
2) Insomnia severity index
3) Baseline values of Visual analogue scale (0-10) of Angamarda, Shirogourava, Jrumba,
Jaadya, Glani, Bhrama, Apakthi, Tandra compared with values of Visual analogue scale (0-
10) on 28 th day.
4) WHO Quality of life scale-Brief
Scored parameters will be analysed statistically after the treatment. All the subjective
parameters and scales will be assessed using Wilcoxon signed rank test within the groups and
Mann-Whitney U test in between the groups. 
observation will be made on 0th,14th and 28th day 
 
Secondary Outcome  
Outcome  TimePoints 
quality of life  0th day and 28th day 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  25/08/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is Ramdomized open labelled parallel group study comparing the safety and efficacy of trial drug
Group A - Vibhitaki phala majja capsule (400mg) 1 HS/ afterfood with warm water.
Group B - Aroma-therapy with Vacha dhupa(5gm) once a day, 10min Before bed time.
Dosage of Group A wiil be 400mg capsule at bed time and for group B Vacha dhupa for 10mins at bed time for 28 days for 15 patients to each group and will be conducted in Shri Dharmashtala Manjunatheswara College of Ayurveda, hosptial and research Centre,kuthpady, Udupi, Karnataka, India. The Primary majors will be assessed through Athens insomnia scale, Insomnia severity index and Baseline values of Visual analogue scale.
The secondary outcome majors will be assessed based on the quality of life scale hence this study is an effort to prove the efficacy of Vibhitaki phala majja capsule and Aroma-therapy with Vacha dhupa in working women w.s.r primary insomnia.
 
Close